About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Safety and Efficacy Study of Albiglutide in Type 2 Diabetes

NCT00849017·262 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

GlaxoSmithKline

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

type 2 diabetes
BMI 20-45kg/m2 inclusive

You may not be if

females who are pregnant, lactating, or \<6 weeks post-partum
CHF NYHA class III-IV

The record

StatusCompleted

PhasePhase 3

Taking part309

StartedJan 2009

UpdatedJan 9, 2017

Conditions

Diabetes Mellitus, Type 2

Where262

GSK Investigational Site
Alabaster, Alabama, United States
GSK Investigational Site
Birmingham, Alabama, United States
GSK Investigational Site
Birmingham, Alabama, United States

Clareo Health | Safety and Efficacy Study of Albiglutide in Type 2 Diabetes